iRhythm Technologies Inc (iRhythm) is a digital healthcare solutions company engaged in providing non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and solutions to address the clinical needs of patients suffering from arrhythmias. iRhythm’s product offerings include Zio XT and Zio AT Patch, a long-term cardiac rhythm monitor. It also develops the Zio Watch in conjunction with its clinically integrated ZEUS System. The company offers ZIO service in the US to physicians, hospitals, and clinics through a direct sales organization. iRhythm is headquartered in San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company iRhythm Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- iRhythm Technologies Inc Company Overview
- iRhythm Technologies Inc Company Snapshot
- iRhythm Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- iRhythm Technologies Inc - Pipeline Analysis Overview
- Business Description
- iRhythm Technologies Inc - Key Facts
- iRhythm Technologies Inc - Major Products and Services
- iRhythm Technologies Inc Pipeline Products by Development Stage
- iRhythm Technologies Inc Pipeline Products Overview
- AI Based Diagnostic - Atrial Fibrillation
- AI Based Diagnostic - Atrial Fibrillation Product Overview
- Zio - Activity & Sleep
- Zio - Activity & Sleep Product Overview
- Zio - Blood Pressure
- Zio - Blood Pressure Product Overview
- Zio - Body & Skin Temperature
- Zio - Body & Skin Temperature Product Overview
- Zio - Heart Rate
- Zio - Heart Rate Product Overview
- Zio - Heart Rate Variability
- Zio - Heart Rate Variability Product Overview
- Zio - Oxygen Saturation
- Zio - Oxygen Saturation Product Overview
- Zio - Respiration Rate
- Zio - Respiration Rate Product Overview
- Zio MCT
- Zio MCT Product Overview
- iRhythm Technologies Inc - Key Competitors
- iRhythm Technologies Inc - Key Employees
- iRhythm Technologies Inc - Key Employee Biographies
- iRhythm Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Affiliate
- Recent Developments
- iRhythm Technologies Inc, Recent Developments
- Jun 23, 2025: New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
- Apr 28, 2025: iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
- Mar 31, 2025: iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio Long-Term Continuous Monitoring for Arrhythmia Detection
- Nov 13, 2024: iRhythm Technologies Received Additional 510(K) Clearance For Zio AT ECG Monitoring System
- Nov 05, 2024: iRhythm Technologies Receives Additional 510(K) Clearance For Zio AT ECG Monitoring System
- Oct 30, 2024: iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio AT Device
- Oct 22, 2024: iRhythm secures 510(k) clearance for Zio device updates after FDA warning
- Sep 12, 2024: iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval
- Sep 09, 2024: iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio Monitor at HRX 2024 Meeting
- Aug 01, 2024: iRhythm Technologies Chief Financial Officer to Step Down on August 31, 2024
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- iRhythm Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- iRhythm Technologies Inc Pipeline Products by Equipment Type
- iRhythm Technologies Inc Pipeline Products by Indication
- iRhythm Technologies Inc, Key Facts
- iRhythm Technologies Inc, Major Products and Services
- iRhythm Technologies Inc Number of Pipeline Products by Development Stage
- iRhythm Technologies Inc Pipeline Products Summary by Development Stage
- AI Based Diagnostic - Atrial Fibrillation - Product Status
- AI Based Diagnostic - Atrial Fibrillation - Product Description
- Zio - Activity & Sleep - Product Status
- Zio - Activity & Sleep - Product Description
- Zio - Blood Pressure - Product Status
- Zio - Blood Pressure - Product Description
- Zio - Body & Skin Temperature - Product Status
- Zio - Body & Skin Temperature - Product Description
- Zio - Heart Rate - Product Status
- Zio - Heart Rate - Product Description
- Zio - Heart Rate Variability - Product Status
- Zio - Heart Rate Variability - Product Description
- Zio - Oxygen Saturation - Product Status
- Zio - Oxygen Saturation - Product Description
- Zio - Respiration Rate - Product Status
- Zio - Respiration Rate - Product Description
- Zio MCT - Product Status
- Zio MCT - Product Description
- iRhythm Technologies Inc, Key Employees
- iRhythm Technologies Inc, Key Employee Biographies
- iRhythm Technologies Inc, Subsidiaries
- iRhythm Technologies Inc, Affiliate
- Glossary
- iRhythm Technologies Inc Pipeline Products by Equipment Type
- iRhythm Technologies Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioTelemetry Inc
- Welch Allyn Inc
- Hill-Rom Holdings Inc
- Mortara Instrument Inc
- Medtronic Plc
- Preventice Solutions, Inc.
- GE HealthCare Technologies Inc
- Spacelabs Healthcare Inc
- Philips Healthcare Informatics Inc
